Dra. Mar Tintore Subirana

Institutions of which it is part

General Hospital

Clinical neuroimmunology

Multiple Sclerosis Centre of Catalonia

Head of Healthcare

I am a Neurologist and Head of Care at the Centre d'Esclerosi Multiple de Catalunya (Cemcat) of the Neurology/Neuroimmunology service of the Vall d'Hebron University Hospital. Since June 2023 I have been Head of Section at the Centre d'Esclerosi Multiple de Catalunya (Cemcat) of the Neurology/Neuroimmunology service of the Vall d'Hebron University Hospital. Since 2021 I have been a professor of Neurology at the University of Vic-Central University of Catalonia (UVic-UCC) and since October 2022 I have been Chair of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS).

Curriculum

I have developed in particular the study of prognostic factors, multiple sclerosis of the child and adolescent, as well as family planning in women with multiple sclerosis. I am currently a member of the Advisory Ethics Committee (CEA) of the Vall d'Hebron University Hospital.

I have published more than 260 articles in national and international journals and am a regular reviewer of indexed journals both national and international. My factor H is currently 60 and until May 2023 my work has received 15,464 citations.
Mar Tintore Subirana

Institutions

General Hospital

Clinical neuroimmunology

Multiple Sclerosis Centre of Catalonia

Head of Healthcare

Vall Hebron Institut de Recerca

Main researcher

Clinical Neuroimmunology

Related news

Premio Nacional Esperanza a la Investigación en EM

A work Led by Vall d'Hebron: Third Edition of Esperanza Nacional Award for Research in MS
22/12/2023
Xavier Montalban i Angela Vidal

The analysis of the optic nerve improves the detection of multiple sclerosis cases
18/12/2023
Dra. Mar Tintoré, Dr. René Carvajal i Dra. Susana Otero-Romero

A single dose of attenuated vaccines could protect MS patients before therapy
19/10/2023
Georgina Arrambide, Carmen Espejo, Álvaro Cobo-Calvo i Javier Villacieros-Álvarez

Anti-MOG antibodies are rare in patients with a first demyelinating flare suggestive of MS
04/10/2023
See more
Related professionals
Jordi Rio

Jordi Rio

Clinical neuroimmunology, General Hospital

See more

Subscribe to our newsletters and be a part of Vall d'Hebron Campus

The acceptance of these terms implies that you give your consent to the processing of your personal data for the provision of the services you request through this portal and, if applicable, to carry out the necessary procedures with the administrations or public entities involved in the processing. You may exercise the mentioned rights by writing to web@vallhebron.cat, clearly indicating in the subject line “Exercise of LOPD rights”.
Responsible entity: Vall d’Hebron University Hospital (Catalan Institute of Health).
Purpose: Subscription to the Vall d’Hebron Barcelona Hospital Campus newsletter, where you will receive news, activities, and relevant information.
Legal basis: Consent of the data subject.
Data sharing: If applicable, with VHIR. No other data transfers are foreseen. No international transfer of personal data is foreseen.
Rights: Access, rectification, deletion, and data portability, as well as restriction and objection to its processing. The user may revoke their consent at any time.
Source: The data subject.
Additional information: Additional information can be found at https://hospital.vallhebron.com/es/politica-de-proteccion-de-datos.